Status:

UNKNOWN

Role of Aortic Valve Composition in Pathophysiology and Diagnosis of Aortic Stenosis

Lead Sponsor:

Medical University of Warsaw

Collaborating Sponsors:

Polish Cardiac Society

Conditions:

Aortic Stenosis

Aortic Valve Disease

Eligibility:

All Genders

18+ years

Brief Summary

The study aims to evaluate composition differences of aortic valves in different stages and phenotypes of aortic stenosis using non-invasive imaging and histology.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • aortic valve replacement or heart transplant as part of standard care decided by the local Heart Team
  • pre-surgical computed tomography angiography
  • informed consent

Exclusion

    Key Trial Info

    Start Date :

    January 1 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2025

    Estimated Enrollment :

    55 Patients enrolled

    Trial Details

    Trial ID

    NCT06136689

    Start Date

    January 1 2022

    End Date

    May 1 2025

    Last Update

    November 18 2023

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Medical University of Silesia

    Katowice, Poland

    2

    Poznan University of Medical Sciences

    Poznan, Poland

    Role of Aortic Valve Composition in Pathophysiology and Diagnosis of Aortic Stenosis | DecenTrialz